EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE 
EMPOWERING MYELOMA ADVOCACY ACROSS EUROPE
Whilst many people will only get mild to moderate symptoms of COVID-19 (coronavirus), myeloma and AL amyloidosis patients should be extra cautious during the current outbreak. The president of Myeloma Patients Europe (MPE), Hans Scheurer, sends a message to MPE members, myeloma and AL amyloidosis patients. Watch it below:
We are seeking a Patient Advocacy Programme Manager to join our growing team!
Myeloma Patients Europe (MPE), an European umbrella organisation representing myeloma and AL amyloidosis patient groups, is seeking an experienced Scientific Engagement Manager to develop the scientific and medical strategy of the organisation and to ensure all organisational programmes are underpinned by sound scientific information.
